These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 328308

  • 1. Immunological studies of the guinea pig L2C leukemia.
    Green I, Forni G, Konen T, Hu CP, Schwartz BD, Kask A, Shevach EM.
    Fed Proc; 1977 Aug; 36(9):2264-7. PubMed ID: 328308
    [No Abstract] [Full Text] [Related]

  • 2. Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens.
    Forni G, Shevach EM, Green I.
    J Exp Med; 1976 May 01; 143(5):1067-81. PubMed ID: 1262783
    [Abstract] [Full Text] [Related]

  • 3. Discussion paper: loss of antigenicity associated with deletion of Ia alloantigens in a mutant line of guinea pig L2C leukemia.
    Forni G, Shevach EM, Green I.
    Ann N Y Acad Sci; 1976 May 01; 276():381-5. PubMed ID: 1071968
    [No Abstract] [Full Text] [Related]

  • 4. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.
    Stevenson GT, Elliott EV, Stevenson FK.
    Fed Proc; 1977 Aug 01; 36(9):2268-71. PubMed ID: 69552
    [No Abstract] [Full Text] [Related]

  • 5. Overview of the structure and function of the major histocompatibility complex of the guinea pig.
    Shevach EM, Schwartz BD.
    Fed Proc; 1977 Aug 01; 36(9):2260-3. PubMed ID: 69551
    [No Abstract] [Full Text] [Related]

  • 6. Molecular basis of T cell dependent genetic control of the immune response in the guinea pig.
    Geczy AF, de Weck AL.
    Prog Allergy; 1977 Aug 01; 22():147-213. PubMed ID: 141047
    [No Abstract] [Full Text] [Related]

  • 7. Mutant lines of guinea pig L2C leukemia. III. The reaction of an alloantiserum detecting idiotypic determinants on a clonally derived guinea pig B cell leukemia with IgM and Ia molecules.
    Konen TG, Green I, Shevach EM, Kask AM, Schwartz BD.
    J Immunol; 1976 Nov 01; 117(5 Pt.2):1966-70. PubMed ID: 62799
    [Abstract] [Full Text] [Related]

  • 8. Identification of a tumor-associated antigen of the guinea pig L2C leukemia by using syngeneic antisera.
    Hu CP, Schwartz BD, Green I.
    J Immunol; 1978 Feb 01; 120(2):597-601. PubMed ID: 74393
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and immunosensitivity of a guinea pig B-cell leukemia subline lacking cell surface Ia antigens.
    Tanio Y, Zbar B.
    Cancer Res; 1985 Jan 01; 45(1):143-8. PubMed ID: 3917369
    [Abstract] [Full Text] [Related]

  • 10. Surface immunoglobulin of guinea-pig leukaemic lymphocytes.
    Stevenson GT, Eady RP, Hough DW, Jurd RD, Stevenson FK.
    Immunology; 1975 May 01; 28(5):807-20. PubMed ID: 48498
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load.
    Stevenson FK, Morris D, Stevenson GT.
    Immunology; 1980 Oct 01; 41(2):313-21. PubMed ID: 6969218
    [Abstract] [Full Text] [Related]

  • 12. Guinea pig L2C leukemia: immunological, virological and clinical aspects: introduction.
    Rhim JS, Green I.
    Fed Proc; 1977 Aug 01; 36(9):2247-8. PubMed ID: 195844
    [No Abstract] [Full Text] [Related]

  • 13. The distribution of histocompatibility antigens on T and B cells in the guinea pig.
    Shevach EM, Rosenstreich DL, Green I.
    Transplantation; 1973 Aug 01; 16(2):126-33. PubMed ID: 4581398
    [No Abstract] [Full Text] [Related]

  • 14. Solubilization and partial characterization of a tumor-associated transplantation antigen of the guinea pig L2C leukemia.
    Hu CP, Konen TG, Hoes C, Green I.
    J Immunol; 1978 May 01; 120(5):1521-5. PubMed ID: 77874
    [Abstract] [Full Text] [Related]

  • 15. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions.
    Gordon J, Anderson VA, Stevenson GT.
    J Immunol; 1982 Jun 01; 128(6):2863-9. PubMed ID: 6804570
    [Abstract] [Full Text] [Related]

  • 16. How T lymphocytes recognize antigen.
    Janeway CA, Jason JM.
    Crit Rev Immunol; 1980 May 01; 1(2):133-64. PubMed ID: 6174271
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG.
    Haematologia (Budap); 1974 May 01; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract] [Full Text] [Related]

  • 19. Generation of lymphokine-activated killer cells in strain 2 guinea pigs and their use in the therapy of L2C, an acute B-cell leukemia.
    Gregg EO, Gregg IC, Green I.
    Cancer Res; 1987 Feb 01; 47(3):723-9. PubMed ID: 3492265
    [Abstract] [Full Text] [Related]

  • 20. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.
    Stevenson FK, Gordon J.
    J Immunol; 1983 Feb 01; 130(2):970-3. PubMed ID: 6600259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.